Institution

Baylor College of Medicine

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

SEP 9, 2026 · PHASE EARLY PHASE 1 TRIAL

Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease

ClinicalTrials.gov

Early-phase uncontrolled trial (Phase 1) examining dietary supplements in Alzheimer's disease with surrogate endpoints (brain glucose uptake, inflammation) and cognition measures; no results yet reported in this registry record.

PreliminaryBaylor College of Medicine Alzheimer Disease NCT04740580

Reported

Planned enrollment52

PhaseEARLY_PHASE1

Primary outcome: Cognition assess…Day 0, 12 weeks, 24 weeks after supplementa…

AUG 4, 2026 · INTERVENTIONAL STUDY

Telehealth Behavioral Activation for Teens

ClinicalTrials.gov

This is a registry record for an ongoing interventional study with no results reported; enrollment is active and outcome data collection is planned but not yet complete.

PreliminaryBehavioral Activation Baylor College of Medicine Depression in Adolescence

Reported

Estimated enrollment250

Age range12–17 years

Treatment duration10 weeks